Provectus announces acceptance of abstract for poster presentation at SID

Provectus Biopharmaceuticals are being presented at the annual meeting of the Society for Investigative Dermatology, to be held May 15-18, 2024 in Dallas, Texas. The accepted SID abstract is titled “Assessing the safety and toxicity of multi-dosed topical Rose Bengal Sodium in a murine model of full-thickness cutaneous injury”. The work underlying this poster presentation is part of an ongoing sponsored research program with Amina El Ayadi, Ph.D., Assistant Professor, Division of Surgical Sciences, Department of Surgery at the University of Texas Medical Branch at Galveston to characterize the effects of RBS on full-thickness cutaneous wounds and during the subsequent phases of wound healing.